Stephanie A S Staras1, Susan T Vadaparampil2, Roshni P Patel3, Elizabeth A Shenkman3. 1. Department of Health Outcomes and Policy, College of Medicine, and The Institute for Child Health Policy, University of Florida, Gainesville, FL, United States. Electronic address: sstaras@ufl.edu. 2. Health Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, FL, United States; Center for Infection Research in Cancer, Moffitt Cancer Center, Tampa, FL, United States; Department of Oncologic Science, College of Medicine, University of South Florida, Tampa, FL, United States. 3. Department of Health Outcomes and Policy, College of Medicine, and The Institute for Child Health Policy, University of Florida, Gainesville, FL, United States.
Abstract
OBJECTIVE: The study aims were to assess the influence of provider recommendations on parental vaccine perceptions and identify the most potent parent vaccine perceptions for HPV vaccine series initiation considering provider recommendation strength. METHODS: We administered a questionnaire and assessed HPV vaccine claims among a stratified-random sample of parents of 9-17 year old girls enrolled in Florida's Medicaid and the Children's Health Insurance Program. Using multivariate analyses, we evaluated the associations between: (1) parent vaccine perceptions and provider recommendation strength, and (2) parent vaccine perceptions and HPV vaccine series initiation (≥1 vaccine claim or positive parental report) controlling for provider recommendation strength. RESULTS: The majority of the 2422 participating parents agreed that the HPV vaccine was safe (61%), would not make girls more likely to have sex (69%), and prevented cervical cancer (71%). About half (44%) reported receiving a strong provider recommendation. Compared to parents without recommendations, parents with strong recommendations had 2 to 7 times higher odds of agreeing that: vaccines are safe, the HPV vaccine is safe, not concerned about side effects, and the vaccine prevents cervical cancer. Even when considering provider recommendation strength, HPV vaccine series initiation was more likely among girls of parents who agreed rather than disagreed that the HPV vaccine was safe [odds ratio (OR)=5.8, 95% confidence interval (CI)=3.1, 11.1], does not cause sex (OR=2.0, 95% CI=1.2, 3.4), prevents cervical cancer (OR=2.0, 95% CI=1.0, 3.4), and prevents HPV infections (OR=1.8, 95% CI=1.0, 3.0). CONCLUSIONS: Parent concerns about HPV vaccine are similar to their concerns about other vaccines. Providers should focus HPV vaccine discussions with parents on vaccine safety and illness prevention.
OBJECTIVE: The study aims were to assess the influence of provider recommendations on parental vaccine perceptions and identify the most potent parent vaccine perceptions for HPV vaccine series initiation considering provider recommendation strength. METHODS: We administered a questionnaire and assessed HPV vaccine claims among a stratified-random sample of parents of 9-17 year old girls enrolled in Florida's Medicaid and the Children's Health Insurance Program. Using multivariate analyses, we evaluated the associations between: (1) parent vaccine perceptions and provider recommendation strength, and (2) parent vaccine perceptions and HPV vaccine series initiation (≥1 vaccine claim or positive parental report) controlling for provider recommendation strength. RESULTS: The majority of the 2422 participating parents agreed that the HPV vaccine was safe (61%), would not make girls more likely to have sex (69%), and prevented cervical cancer (71%). About half (44%) reported receiving a strong provider recommendation. Compared to parents without recommendations, parents with strong recommendations had 2 to 7 times higher odds of agreeing that: vaccines are safe, the HPV vaccine is safe, not concerned about side effects, and the vaccine prevents cervical cancer. Even when considering provider recommendation strength, HPV vaccine series initiation was more likely among girls of parents who agreed rather than disagreed that the HPV vaccine was safe [odds ratio (OR)=5.8, 95% confidence interval (CI)=3.1, 11.1], does not cause sex (OR=2.0, 95% CI=1.2, 3.4), prevents cervical cancer (OR=2.0, 95% CI=1.0, 3.4), and prevents HPV infections (OR=1.8, 95% CI=1.0, 3.0). CONCLUSIONS: Parent concerns about HPV vaccine are similar to their concerns about other vaccines. Providers should focus HPV vaccine discussions with parents on vaccine safety and illness prevention.
Authors: Jessica A Kahn; H Paul Cooper; Susan T Vadaparampil; Barbara C Pence; Armin D Weinberg; Salvatore J LoCoco; Susan L Rosenthal Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-08 Impact factor: 4.254
Authors: Christina Dorell; David Yankey; Jenny Jeyarajah; Shannon Stokley; Allison Fisher; Lauri Markowitz; Philip J Smith Journal: Clin Pediatr (Phila) Date: 2014-01-24 Impact factor: 1.168
Authors: Shalanda A Bynum; Stephanie A S Staras; Teri L Malo; Anna R Giuliano; Elizabeth Shenkman; Susan T Vadaparampil Journal: J Adolesc Health Date: 2013-09-21 Impact factor: 5.012
Authors: Susan L Rosenthal; Richard Rupp; Gregory D Zimet; Heather M Meza; Melissa L Loza; Mary B Short; Paul A Succop Journal: J Adolesc Health Date: 2008-09 Impact factor: 5.012
Authors: Luisa A Watts; Naima Joseph; Maria Wallace; Jose A Rauh-Hain; Alona Muzikansky; Whitfield B Growdon; Marcela G del Carmen Journal: Gynecol Oncol Date: 2009-01-15 Impact factor: 5.482
Authors: Philip James Edwards; Ian Roberts; Mike J Clarke; Carolyn Diguiseppi; Reinhard Wentz; Irene Kwan; Rachel Cooper; Lambert M Felix; Sarah Pratap Journal: Cochrane Database Syst Rev Date: 2009-07-08
Authors: Lila J Finney Rutten; Jennifer L St Sauver; Timothy J Beebe; Patrick M Wilson; Debra J Jacobson; Chun Fan; Carmen Radecki Breitkopf; Susan T Vadaparampil; Kathy L MacLaughlin; Robert M Jacobson Journal: Vaccine Date: 2017-09-27 Impact factor: 3.641
Authors: Alexandria C Caldwell; Christi A Madden; David M Thompson; M Connor Garbe; James R Roberts; Robert M Jacobson; Paul M Darden Journal: Hum Vaccin Immunother Date: 2020-10-19 Impact factor: 3.452
Authors: Stephanie A S Staras; Susan T Vadaparampil; Melvin D Livingston; Lindsay A Thompson; Ashley H Sanders; Elizabeth A Shenkman Journal: J Adolesc Health Date: 2015-05 Impact factor: 5.012